|
Are Sun
Screens Safe - The Rest
of The Story
EWG research shows that
84% of 910 name-brand sunscreen products offer inadequate protection
from the sun, or contain ingredients, like oxybenzone, with significant
safety concerns.
The last safety review for oxybenzone was done in the 1970s, and does
not reflect a wealth of information developed since that time indicating
increased toxicity concerns and widespread human exposure. A recent
review in the European Union found that sufficient data were not
available to assess if oxybenzone in sunscreen was safe for consumers.
Environmental Working Group again calls on FDA to review the safety of
oxybenzone, given this new data on widespread contamination of the U.S.
population, and to finalize its sunscreen safety standards so that
consumers can be certain that sunscreen products they purchase are safe
and effective.
CDC study of oxybenzone signals concern
Top scientists from CDC published results March 21, 2008 from a national
survey of 2,500 Americans, age 6 and up, showing that oxybenzone readily
absorbs into the body and is present in 97% of Americans tested (Calafat
2008). Oxybenzone, also known as benzophenone-3, was detected in the
urine of nearly every study participant. Typically, women and girls had
higher levels of oxybenzone in their bodies than men and boys, likely a
result of differences in use of body care products including sunscreens.
A companion study released a day earlier revealed that mothers with high
levels of oxybenzone in their bodies were more likely to give birth to
underweight baby girls (Wolff 2008). Low birth weight is a critical risk
factor linked to coronary heart disease, hypertension, type 2 diabetes,
and other diseases in adulthood (Lau 2004).
Oxybenzone damages and penetrates the skin
Among common sunscreen chemicals, oxybenzone is most likely to be
associated with allergic reactions triggered by sun exposure. In a study
of 82 patients with photoallergic contact dermatitis, over one quarter
showed photoallergic reactions to oxybenzone (Rodriguez 2006); another
study reported 1 in 5 allergic reactions to photopatch tests resulted
from exposure to oxybenzone (Bryden 2006).
Sunlight also causes oxybenzone to form free radical chemicals that may
be linked to cell damage, according to 2 of 3 studies (Allen 1996;
Serpone 2002; Hanson 2006).
A less visible but more alarming concern, this chemical absorbs through
the skin in significant amounts, as indicated by the CDC study. A
previous biomonitoring study reported that 96% of 6 to 8 year old girls
had detectable amounts of oxybenzone in their urine (Wolff 2007). An
earlier study detected oxybenzone in the urine of all 30 adult
participants (Ye 2005).
Studies on human volunteers indicate a wide variation in the level of
oxybenzone absorbed into the body, with some individuals absorbing at
least 9% of the applied dose, as measured in excretions in urine (Hayden
1997; Janjua 2004; Sarveiya 2004; Gonzalez 2006). Volunteers continued
to excrete oxybenzone many days after the last application of the
chemical, an indication of its tendency to accumulate in fatty tissues
in the body (Gonzalez 2006).
In addition to its ability to absorb into the body, oxybenzone is also a
penetration enhancer, a chemical that helps other chemicals penetrate
the skin (Pont 2004).
Oxybenzone may disrupt the human hormone system
Studies on cells and laboratory animals indicate that oxybenzone and its
metabolites, the chemicals the body makes from oxybenzone in an attempt
to detoxify and excrete it, may disrupt the hormone system. Under study
conditions, oxybenzone and its metabolites cause weak estrogenic
(Nakagawa 2002; Schlumpf 2001, 2004; Kunz 2006; van Liempd 2007) and
anti-androgenic (Ma 2003) effects. Oxybenzone displays additive hormonal
effects when tested with other sunscreen chemicals (Heneweer 2005).
Laboratory study also suggests that oxybenzone may affect the adrenal
hormone system (Ziolkowska 2006).
One human study coapplying 3 sunscreen active ingredients (oxybenzone,
4-MBC, and octinoxate) suggested a minor, intermittent, but
statistically significant drop in testosterone levels in men during a
one-week application period (Janjua 2004). Researchers also detected
statistically significant declines in estradiol levels in men; other
hormonal differences detected could not be linked to sunscreen use due
to differences in baseline hormone levels before and during treatment.
Outdated health protections do not take into account these and other
adverse effects
A 2006 European Union review concluded that a rigorous exposure
assessment of oxybenzone was impossible, due to lack of information
about the levels of absorption into the body (SCCP 2006). The levels of
contamination reported in this latest CDC study indicate that absorption
may be significant, consistent with previous, small-scale biomonitoring
reports. A decades-old evaluation by FDA, as well as more recent review
by the cosmetics industry's own safety panel, do not consider concerns
regarding hormone disruption, nor the implications of the ability of
oxybenzone to penetrate the skin (FDA 1978; CIR 1983, 2002). At present,
no health-based standards exist for safe levels of oxybenzone in the
body.
Additional cautions must be employed when considering the effects of
oxybenzone on children. The surface area of a child's skin relative to
body weight is greater than adults. As a result, the potential dose of a
chemical following dermal exposure is likely to be about 1.4 times
greater in children than in adults (SCCNFP 2001). In addition, children
are less able than adults to detoxify and excrete chemicals, and
children's developing organ systems are more vulnerable to damage from
chemical exposures, and more sensitive to low levels of hormonally
active compounds (NAS 1993; Janjua 2004). Children also have more years
of future life in which to develop disease triggered by early exposure
to chemicals (NAS 1993). Despite these well-documented concerns
regarding children's sensitivity to harmful substances, no special
protections exist regarding ingredients in personal care products
marketed for babies and children.
The fraction of oxybenzone that is not absorbed into the human body
often contaminates water, washed from the skin during swimming and water
play or while bathing (Lambropolou 2002; Danovaro 2008). Wastewater
treatment removes only a fraction of this sunscreen chemical (Li 2007),
resulting in detection of oxybenzone in treated wastewater, in lake and
sea waters due to recreational use or to discharges from water treatment
facilities, and even in fish (Balmer 2005; Cuderman 2007; Li 2007).
Studies show oxybenzone can trigger outbreaks of viral infection in
coral reefs (Danovaro 2008), and can cause feminization of male fish
(Kunz 2006). Despite significant ecological concerns, there are no
measures in place to protect sensitive ecosystems from damage caused by
this contaminant.
EWG to FDA: Oxybenzone investigation is long overdue
FDA last reviewed the safety of oxybenzone in the 1970s, publishing its
evaluation in 1978, at the same time it announced plans to develop
comprehensive standards for sunscreen safety and effectiveness (FDA
1978). 30 years later, the Agency has yet to issue final regulations.
Instead, it encourages manufacturers to follow draft guidelines that the
Agency has delayed finalizing at the behest of the sunscreen industry.
As a result, sunscreen manufacturers in the U.S. are free to market
products containing ingredients like oxybenzone that have not been
proven safe for people.
Found in over half of the 910 name-brand sunscreen products we reviewed,
oxybenzone is tied to significant health concerns that must be
scrutinized. Instead, FDA's refusal to re-examine this ingredient keeps
sunscreens containing oxybenzone on the market. Petitions for review of
newly developed sunscreen ingredients approved for use in other
countries, and with far fewer health concerns, have been met with
similar inattention, blocking Americans' access to better products.
FDA foot-dragging has left the U.S. without enforceable standards for
sunscreen safety and effectiveness for decades. EWG demands that FDA
finalize the latest version of its monograph on sunscreen products
immediately, and launch an investigation into the safety of the
sunscreen ingredient oxybenzone. |